Protocolo de estudio y tratamiento de la trombocitopenia inmune primariaPTI-2018

  1. Emilio Monteagudo
  2. Itziar Astigarraga
  3. Áurea Cervera
  4. María Angeles Dasí
  5. Ana Sastre
  6. Rubén Berrueco
  7. José Luis Dapena
Aldizkaria:
Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP )

ISSN: 1695-4033,  1696-4608

Argitalpen urtea: 2019

Alea: 91

Zenbakia: 2

Orrialdeak: 127-127

Mota: Artikulua

DOI: 10.1016/J.ANPEDI.2019.04.014 DIALNET GOOGLE SCHOLAR lock_openSarbide irekia editor

Beste argitalpen batzuk: Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP )

Laburpena

Primary immune thrombocytopenia, formerly known as immune thrombocytopenic purpura, is a disease for which the clinical and therapeutic management has always been controversial. The ITP working group of the Spanish Society of Paediatric Haematology and Oncology has updated its guidelines for diagnosis and treatment of primary immune thrombocytopenia in children, based on current guidelines, bibliographic review, clinical assays, and member consensus. The main objective is to reduce clinical variability in diagnostic and therapeutic procedures, in order to obtain best clinical results with minimal adverse events and good quality of life.

Datuen iturria: Dialnet